The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a ...

New Scripps Research trial will explore the effects of Lilly’s GLP-1 drug on reducing the symptoms of the debilitating ...

Researchers from Singapore General Hospital (SGH) and National University of Singapore (NUS) found that using pulsed ...

Adolescents and young adults with preexisting autoimmune disease are more likely to develop type 1 diabetes than those ...

Researchers from the University at Albany and NYU Grossman School of Medicine have found a way to block a key cellular ...

Starting Oct. 1, 2025, a new diagnosis code was added to the detailed list of codes used by health care providers: the remission of type 2 diabetes.

Millions of Americans have diabetes and regular blood sugar monitoring is crucial. A team of researchers is working on a new ...

In a large real-world Italian cohort, GLP-1 receptor agonist therapy led to measurable rates of type 2 diabetes remission, ...

Diabetes incidence was higher among postmenopausal women who reported SARS-CoV-2 infection, multiple COVID-19 symptoms, or COVID-19 hospitalization.

The obesity rate in the U.S. dropped to 37% this year, representing a notable decrease after reaching a record high of 39.9% ...

Researchers at University of Tsukuba reported that using manga as an educational tool in diabetes instruction for children ...